Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,929 studies match

clinicaltrialsPublishedShowing 1–50 of 1,929 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03358472	Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)	completed	Phase 3	89	Incyte CorporationINDUSTRY	14	Sep 29, 2026	clinicaltrials
NCT03395197	Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC(TALAPRO-2)	active not recruiting	Phase 3	1,054	PfizerINDUSTRY	26	Sep 29, 2026